GWSG
ARCT icon

GPS Wealth Strategies Group’s Arcturus Therapeutics ARCT Stock Holding History

GPS Wealth Strategies Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$232 – 1382
2024
Q3 		$232 Hold
10
– – ﹤0.01% 1352
2024
Q2 		$244 Hold
10
– – ﹤0.01% 1316
2024
Q1 		$338 Buy
+10
New +$354 ﹤0.01% 1202

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GPS Wealth Strategies Group's ARCT Position: Q4 2024 in Review

GPS Wealth Strategies Group sold out of Arcturus Therapeutics (ARCT) in Q4 2024, closing a stake of 10 shares — an estimated $232 sold.

GPS Wealth Strategies Group first reported a position in ARCT in Q1 2024 and held it in 3 quarters. The position peaked at $338 in Q1 2024. 147 funds tracked by Wall St. Rank hold ARCT as of Q4 2024.

  • GPS Wealth Strategies Group reported no remaining Arcturus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 10 Arcturus Therapeutics shares in Q4 2024, an estimated $232.
  • GPS Wealth Strategies Group first reported a position in Arcturus Therapeutics in Q1 2024 and held it in 3 quarters.
  • GPS Wealth Strategies Group's Arcturus Therapeutics position peaked at $338 in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2024, filed 24 Jan 2025.